Advances In Diabetes For Better Quality Of Life

To discuss the current state of diabetes care in America, the value and utility of innovative diabetes technologies, barriers to access to quality diabetes care and technologies, and how a value-based model of diabetes care can improve outcomes and ... To discuss the current state of diabetes care in America, the value and utility of innovative diabetes technologies, barriers to access to quality diabetes care and technologies, and how a value-based model of diabetes care can improve outcomes and ... Jan 22, 2026 · And yet there’s never been a better time to tackle it. With powerful new medications, wearable blood sugar monitors and insulin pumps, research-proven prevention strategies and better (though far from perfect) insurance coverage for testing, prevention and treatment, winning the war on diabetes is more possible than ever. Jan 22, 2026 · And yet there’s never been a better time to tackle it. With powerful new medications, wearable blood sugar monitors and insulin pumps, research-proven prevention strategies and better (though far from perfect) insurance coverage for testing, prevention and treatment, winning the war on diabetes is more possible than ever. Feb 25, 2025 · Conclusion Diabetes technology has been shown to improve important aspects of diabetes care, from glycemic control to patient satisfaction and quality of life . It is important to assess the role of technology in type 1 and type 2 diabetes and individualize treatment goals and objectives. Feb 25, 2025 · Conclusion Diabetes technology has been shown to improve important aspects of diabetes care, from glycemic control to patient satisfaction and quality of life . It is important to assess the role of technology in type 1 and type 2 diabetes and individualize treatment goals and objectives. Arrojo e Drigo believes that people with or at risk for diabetes may have fewer ‘young’ beta-cells, which are likely to function better than old ones. Alternatively, if we can figure out how to induce the production of younger, high-functioning beta-cells in the pancreas, it could be a potential treatment for people with diabetes . Arrojo e Drigo believes that people with or at risk for diabetes may have fewer ‘young’ beta-cells, which are likely to function better than old ones. Alternatively, if we can figure out how to induce the production of younger, high-functioning beta-cells in the pancreas, it could be a potential treatment for people with diabetes . Advances in connected continuous glucose monitoring devices, insulin pumps, and insulin pens have led to the ...